Arrested: The Resistant Bacteria Group
Description
Healthcare professionals face a critical, life-threatening challenge in wound management: highly resistant bacteria strains that standard treatments fail to eradicate. The objective was to create a disruptive, non-clinical visual for Actolind W that immediately communicated its efficacy against these stubborn superbugs to medical professionals.
We personified the deadly, drug-resistant bacteria (MRSA, VRE, MRE) as a notorious gang of fugitives. Framing the layout as a breaking news front page titled "The Wound Care News," the campaign announces that this resistant group has finally been "Arrested". The bold copy emphasizes that while standard antibiotics, antiseptics, and disinfectants failed to capture them, Actolind W succeeded. This striking visual metaphor cuts through traditional pharmaceutical advertising, instantly positioning the product as the ultimate authority in infection control.
This professional campaign titled 'Arrested: The Resistant Group' was published in Saudi Arabia in September, 2026. It was created for the brand: Actolind W, by ad agency: PROMO PHARMA. This Design, Print, and Static Images media campaign is related to the Health and Pharmaceutical industries and contains 1 media asset. It was submitted about 1 hour ago by CEO: Dr. Kamal Fayad of PROMO PHARMA.
Credits
Advertising Agency: PROMO-PHARMA, Jeddah, Saudi Arabia
Creative Director: Dr. Kamal El-Deen Fayad
Art Direction & Medical Copywriting: PROMO-PHARMA Team
